Objective: To assess the complete vascular risk factor (VRF) profile of idiopathic normal pressure hydrocephalus (INPH) using a large sample of representative patients with INPH and populationbased controls to determine the extent to which vascular disease influences INPH pathophysiology.
Idiopathic normal pressure hydrocephalus (INPH) is a surgically treatable cause of dementia and is characterized by ventriculomegaly, gait disturbances, cognitive decline, and urinary symptoms. 1, 2 The underlying causes of INPH are largely unknown. The clinical picture resembles that of subcortical atherosclerotic encephalopathy or Binswanger disease. 3, 4 An emerging concept is that the pathophysiology of INPH is multifactorial and that the well-described CSF hydrodynamic dysfunction in INPH may be combined with subcortical vascular dementia (VaD). 1, [3] [4] [5] [6] [7] [8] If INPH is a subtype of VaD, vascular risk factor (VRF) management may be beneficial for the treatment of patients with INPH. This would be an additional noninvasive treatment option for patients with INPH.
INTERHEART 9 and INTERSTROKE 10 are 2 of the largest population-based VRF studies. These studies have proven that 9 and 10 VRFs, respectively, account for 90% of all myocardial infarctions and strokes. There are no similar studies combining multiple VRFs in patients with INPH. Hypertension is perhaps the most important VRF for INPH, 3 and cerebrovascular disease (CVD) (e.g., stroke and white matter hyperintensities) is frequently comorbid with INPH. [3] [4] [5] There are indications that other VRFs, such as diabetes and cardiac disease, may be overrepresented in INPH. [11] [12] [13] [14] [15] However, existing studies are small and have several methodologic limitations.
The INPH-Comorbidity and Risk Factors Associated With Hydrocephalus (CRasH) study is a large, prospective, case-control study comparing all patients with INPH who have undergone shunting in Sweden between 2008 and 2010 to population-based controls. 8 The hypothesis for the study was that VRFs and subsequent vascular disease (VaDis) are overrepresented in INPH. The objective was to assess the total VRF profile in definitive cases of INPH and to determine the extent to which VaDis influences INPH pathophysiology.
METHODS
In the INPH-CRasH study, VRFs and VaDis in 176 consecutive patients with INPH who had undergone shunting were compared to those in 368 age-and sex-matched population-based controls. The participants completed an extensive questionnaire, had a standardized visit to their health care provider, and donated a blood sample.
Identification of study participants. Patients with INPH
were identified through the Swedish Hydrocephalus Quality Registry (SHQR), where all adult ($18 years) individuals who have undergone shunting due to hydrocephalus in Sweden are registered. During the study period, the registry covered 5 of 6 neurosurgical units (referral area for 80% of the Swedish population). The data used from the SHQR were as follows: date of birth, sex, Prospective ascertainment of risk factors. First, each participant completed a questionnaire regarding demographics, illnesses, somatic and mental symptoms, medications, and lifestyle, followed by a standardized visit at the nearest health care provider. There, blood samples (analyzed for serum glucose, ApoB, ApoA1, ratio of ApoB to ApoA1, and plasma creatinine), blood pressure (3 measurements taken after a minimum 10-minute rest), ECGs, height, weight, and waist-to-hip ratio 9 were obtained. The use of lipid-lowering drugs was assessed using the Swedish national drug registry, where all medication prescribed in Sweden is registered. For details regarding each of the VRFs we investigated, see table e-1 at Neurology.org.
Statistical analyses. SPSS-21 (SPSS Inc., Chicago, IL) was used for statistical analysis. Significance was set at 0.05 (2-sided). For categorical variables, logistic regression was used to calculate crude and adjusted (for age and sex) odds ratios (ORs). Analyses of covariance were used for continuous variables (covariates: age and sex). When building the multivariable logistic regression models, manual backwards analysis was used. Only participants who had data for all of the parameters were included. To calculate the population-attributable risk percent (PAR%), the regpar routine in STATA 13 was used. For comparisons between patients who had their shunt surgeries in each of the 3 years of the study, a x 2 test and an analysis of variance were used. When conducting the comparative case-control analyses, the matching requirement was waived for 2 reasons. First, there were 5 patients with INPH whose data arrived at the end of December 2011. Since the recruitment period ended in 2011, these patients did not have individually matched controls. Second, for 33 cases, all controls declined to participate. Strictly matched analyses would have excluded all of these participants from the analyses and valuable information would have been lost. Thus, the findings presented here are obtained from models fit with unconditional logistic regression and adjusted for the matching criteria. This is the same approach used in INTERHEART 9 and INTERSTROKE. 10 Power calculations performed before the study revealed that with a proposed sample size of 200 cases and 400 controls, the study would have a power of 87.4%, assuming that the mean percentage of participants with hypertension is 45% in patients with INPH 16 and 32% in the general population.
10
Standard protocol approvals, registrations, and patient consents. The INPH-CRasH study was carried out in accordance with the Declaration of Helsinki and was approved by the ethical review board at Umeå University. The study is registered at clinicaltrials.gov (NCT01850914). Participants were informed of the study in a covering letter. Each participant provided informed consent by sending back the filled-in questionnaire.
RESULTS Table 1 Table 3 Lipid profiles of patients with idiopathic normal pressure hydrocephalus (INPH) and the general population 12 However, the levels of apolipoproteins have not been studied previously in this population. In this study, patients with INPH had higher levels of disease-associated apolipoproteins than controls, based on all measures tested. This difference was not explained by a difference in the prescription of lipid-lowering drugs. These results indicate a strong association between INPH and hyperlipidemia. Manifest PVD and CVD were also overrepresented in patients with INPH. The strongest association was found for renal dysfunction; however, an association was also found for chronic kidney disease. Renal dysfunction and chronic kidney disease have not been described previously in INPH. Decreased renal function is a risk factor for both dementia and CVD, particularly cerebral small vessel disease (SVD). 19 In addition, decreased renal function is associated with increased plasma concentrations of ApoB. 20 Our results suggest a strong association between INPH and abdominal obesity. High BMI has previously been reported to correlate with high lumbar CSF opening pressure. 21 However, otherwise, obesity has rendered little interest in studies regarding INPH. Physical inactivity was also associated with INPH. Since gait disturbance is one of the cardinal symptoms of INPH and physical inactivity is associated with obesity, the clinical relevance of this association is uncertain. However, abdominal obesity was associated with INPH even after adjusting for physical inactivity.
Psychosocial factors are some of the most important VRFs. 9, 10 In fact, this VRF had the second highest adjusted OR in this study. We have already shown that symptoms of depression are overrepresented in patients with INPH. 8 A recent review identified psychosocial factors, mainly depression, as some of the most important modifiable VRFs for dementia prevention. 17 In contrast with previous studies, 3,11-14 our study indicates that hypertension is not independently associated with INPH. This does not necessarily mean that hypertension is not a VRF for INPH. Nowadays, there is a general high awareness of and improved treatment for hypertension. Approximately 60% of all participants were using antihypertensive treatments. In addition, the blood pressure measurements were obtained at 1 time point and do not indicate the longitudinal blood pressure in each individual. In contrast with previous studies, [12] [13] [14] there was no association between cardiac disease and INPH. One explanation may be related to our exclusion of patients with severe dementia, who comprise a group with a presumably high frequency of cardiac disease. Furthermore, due to the risk of perioperative and postoperative complications, patients with severe coronary artery disease may not have been considered suitable for shunt surgery during the standard preoperative evaluation.
Comorbidity is an important predictor of the prognosis and long-time outcome of shunting in INPH. 3, 5, 6, 22 Vascular comorbidity may be associated with more severe symptoms and less postoperative improvement. 5 However, most researchers agree that patients with extensive CVD should not be excluded from shunting. [3] [4] [5] [6] There are not many reports regarding the effects of coexisting VRFs on shunting.
3,5 However, VRFs most often lead to VaDis. Most VRFs are treatable, either by lifestyle changes or by medication, recommended for the treatment of other dementias. 17 Thus, we recommend that a thorough VRF analysis should be performed during the evaluation of patients with INPH, and that treatment for existing VRFs should be initiated.
INPH should be suspected when a patient presents with gait disturbances and VRFs. In a study examining hydrocephalic symptoms and ventriculomegaly in a population with CVD, 4% of the patients fulfilled the diagnostic criteria for possible INPH. 23 In a recent study, patients with Binswanger disease benefitted from shunting. 4 More studies on this subject are needed and a prospective trial of shunting on the basis of INPH symptoms, ventriculomegaly, and VRFs should be conducted. In addition, patients diagnosed with INPH should be compared to those diagnosed with VaD according to criteria such as those of the National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche en l'Enseignement en Neurosciences. Considering the results in the present study together with repeated underdiagnosis and undertreatment of INPH, 24, 25 we suggest that when hydrocephalic symptoms and VRFs coexist with ventriculomegaly, the patient should be evaluated with tests specific for INPH (e.g., hydrodynamic testing, tap test, or extended lumbar drainage).
In agreement with previous studies, we found that CVD is overrepresented in INPH. 1, 3 Both subtypes of CVD are commonly seen in patients with INPH. The 2 types of CVD are SVD (e.g., white matter hyperintensities and lacunar infarctions) and large vessel disease (LVD) (e.g., stroke and TIA). 3, 23 Since LVD and SVD have different pathophysiologic pathways, they may contribute differently to INPH. The atherosclerosis of large vessels in LVD is well-described. In SVD, the roles of VRFs are not completely understood. In agreement with this study, other reports indicate that diabetes, hyperlipidemia, hypertension, and chronic kidney disease are risk factors. 19, 26 One hypothesis is that increased vascular stiffness with reduced dampening of arterial blood pressure and increased pulse pressure exposes the small vessels of the brain to increased wall stress. 26, 27 Endothelial failure and increased vascular permeability lead to chronic inflammation, damage to the blood-brain barrier, and an accumulation of toxic metabolites. At later stages, luminal narrowing and occlusion occur and precipitate ischemia, infarction, and impaired blood flow and metabolism in the deep white matter. 26, 27 Increased CSF pulsation may be one of the pathophysiologic explanations for INPH. 28 Patients with INPH exhibit characteristics similar to those of patients with SVD. These characteristics include reduced periventricular metabolism, reduced cerebral blood flow in the periventricular and frontal subcortical areas of the brain, lacunar infarctions, and microbleeds. 3, [29] [30] [31] Biomarkers of axonal damage and chronic ischemia have also been found in the CSF of patients with INPH. 3, 16, 29 Thus, we suggest that SVD and its VRFs in combination with increased CSF pulsations may be important parts of a pathophysiologic pathway in INPH. If the stiffening of central arteries causes a chronic increase in cerebral arterial pulsatility, which indirectly increases CSF pulsations, a lowering of intracranial pressure with shunting would increase intracranial compliance and potentially normalize the pulsations. In addition, the alternate route for CSF outflow that a shunt provides could, hypothetically, moderate the vicious cycle of SVD by facilitating the transportation of toxic metabolites, leading to reduced inflammation and probably increased cerebral blood flow and increased metabolism. More studies are needed.
The strengths of this study include large samples of representative cases and controls, a proper diagnosis of INPH, and population-based controls without selection bias. These factors should lead to high generalizability for our study. In order to minimize bias in collecting data and to increase internal validity, all data were assessed in the same standardized manner for all participants. One limitation of our study was the exclusion of patients with MMSE scores ,23, which may have increased the risk of a type 2 error. This rather strengthens the associations between the VRFs and INPH. However, some of the associations may have been stronger if the patients with the lower MMSE scores were included. Another limitation was that the VRFs were assessed postoperatively and that the VRF profiles of patients with suspected INPH who did not undergo shunting are unknown. Thus, this study does not prove causality. Theoretically, the VRFs may not have existed before the surgery. However, there is little reason to believe this. VRFs and subsequent VaDis develop over a long period and there was no difference in VRFs between patients with INPH from the 3 different years of surgery. The results of this study confirm and extend the findings of previous risk factor studies conducted before shunting. [11] [12] [13] [14] [15] There are several plausible pathophysiologic explanatory models for VRFs acting as risk factors for INPH. However, there are no models suggesting INPH as a risk factor for VaDis. Other limitations include the fact that CVD was self-reported and that even though the calculated PAR% was 24, the potential for prevention could not be proved using our data.
Patients with INPH have higher rates of VRFs and VaDis than the general population. Hyperlipidemia, abdominal obesity, diabetes, and psychosocial factors are associated with INPH independently of age, sex, and other VRFs. In addition, hypertension, CVD, and PVD are overrepresented in INPH. In the entire population, 24% of cases of INPH may be explained by VRFs. This suggests that INPH may be a subtype of VaD. SVD may have an important role in the pathophysiology of INPH. A VRF analysis should be undertaken in the preoperative evaluation of each patient with INPH and treatment for existing VRFs should probably be initiated, whether the patient is selected to undergo shunting or not.
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